Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Impact of Autoimmune Thyroiditis on Reproductive and Metabolic Parameters in Patients with Polycystic Ovary Syndrome.

Ulrich J, Goerges J, Keck C, Müller-Wieland D, Diederich S, Janssen OE.

Exp Clin Endocrinol Diabetes. 2018 Apr;126(4):198-204. doi: 10.1055/s-0043-110480. Epub 2018 Mar 5.

PMID:
29506313
2.

Directional thyroid hormone distribution via the blood stream to target sites.

Janssen ST, Janssen OE.

Mol Cell Endocrinol. 2017 Dec 15;458:16-21. doi: 10.1016/j.mce.2017.02.037. Epub 2017 Feb 28. Review.

PMID:
28257828
3.

Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome.

Knebel B, Lehr S, Janssen OE, Hahn S, Jacob S, Nitzgen U, Müller-Wieland D, Kotzka J.

Mol Biol Rep. 2017 Feb;44(1):51-61. doi: 10.1007/s11033-016-4080-1. Epub 2016 Nov 22.

PMID:
27878529
4.

Two Novel Mutations in the Serpina7 Gene Are Associated with Complete Deficiency of Thyroxine-Binding Globulin.

Moeller LC, Appiagyei-Dankah Y, Köhler B, Biebermann H, Janssen OE, Führer D.

Eur Thyroid J. 2015 Sep;4(Suppl 1):108-12. doi: 10.1159/000381093. Epub 2015 May 30.

5.

Thyroid autoantibodies per se do not impair intracytoplasmic sperm injection outcome in euthyroid healthy women.

Tan S, Dieterle S, Pechlavanis S, Janssen OE, Fuhrer D.

Eur J Endocrinol. 2014 Mar 8;170(4):495-500. doi: 10.1530/EJE-13-0790. Print 2014 Apr.

PMID:
24394727
6.

[Acne tarda. Acne in adults].

Jansen T, Janßen OE, Plewig G.

Hautarzt. 2013 Apr;64(4):241-51. doi: 10.1007/s00105-012-2458-0. German.

PMID:
23576169
7.

Genetic variants in central metabolic genes influence some but not all relations of inflammatory markers in a collective with polycystic ovary syndrome.

Knebel B, Lehr S, Janssen OE, Hahn S, Nitzgen U, Jacob S, Haas J, Muller-Wieland D, Kotzka J.

Arch Physiol Biochem. 2012 Oct;118(4):219-29. doi: 10.3109/13813455.2012.697903. Epub 2012 Jun 28.

PMID:
22738153
8.

Genetic variations in SREBP-1 and LXRα are not directly associated to PCOS but contribute to the physiological specifics of the syndrome.

Knebel B, Janssen OE, Hahn S, Jacob S, Nitzgen U, Haas J, Muller-Wieland D, Kotzka J.

Mol Biol Rep. 2012 Jun;39(6):6835-42. doi: 10.1007/s11033-012-1508-0. Epub 2012 Feb 4.

PMID:
22311022
9.

[Thyroid and pregnancy].

Barthel A, Keck C, Janssen OE, Bornstein SR, Benker G.

Dtsch Med Wochenschr. 2012 Feb;137(5):171-4. doi: 10.1055/s-0031-1298810. Epub 2012 Jan 25. Review. German. No abstract available.

PMID:
22278684
10.

Identification of a gene variant in the master regulator of lipid metabolism SREBP-1 in a family with a novel form of severe combined hypolipidemia.

Kotzka J, Knebel B, Janssen OE, Schaefer JR, Soufi M, Jacob S, Nitzgen U, Muller-Wieland D.

Atherosclerosis. 2011 Sep;218(1):134-43. doi: 10.1016/j.atherosclerosis.2011.05.008. Epub 2011 May 18.

PMID:
21645898
11.

[47-year-old man with fatigue and hair loss].

Janssen OE.

Dtsch Med Wochenschr. 2011 Mar;136(11):523-4. doi: 10.1055/s-0031-1274536. Epub 2011 Mar 8. German. No abstract available.

PMID:
21387210
12.

[Atypical presentation of subacute thyroiditis].

Janssen OE.

Dtsch Med Wochenschr. 2011 Mar;136(11):519-22. doi: 10.1055/s-0031-1274535. Epub 2011 Mar 8. German.

PMID:
21387209
13.

Stanniocalcin 1 induction by thyroid hormone depends on thyroid hormone receptor β and phosphatidylinositol 3-kinase activation.

Moeller LC, Haselhorst NE, Dumitrescu AM, Cao X, Seo H, Refetoff S, Mann K, Janssen OE.

Exp Clin Endocrinol Diabetes. 2011 Feb;119(2):81-5. doi: 10.1055/s-0030-1262860. Epub 2010 Sep 8.

14.

Maladaptive coping with illness in women with polycystic ovary syndrome.

Benson S, Hahn S, Tan S, Janssen OE, Schedlowski M, Elsenbruch S.

J Obstet Gynecol Neonatal Nurs. 2010 Jan-Feb;39(1):37-45. doi: 10.1111/j.1552-6909.2009.01086.x.

PMID:
20409101
15.

Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).

Tan S, Scherag A, Janssen OE, Hahn S, Lahner H, Dietz T, Scherag S, Grallert H, Vogel CI, Kimmig R, Illig T, Mann K, Hebebrand J, Hinney A.

BMC Med Genet. 2010 Jan 21;11:12. doi: 10.1186/1471-2350-11-12.

16.

Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome.

Tan S, Bechmann LP, Benson S, Dietz T, Eichner S, Hahn S, Janssen OE, Lahner H, Gerken G, Mann K, Canbay A.

J Clin Endocrinol Metab. 2010 Jan;95(1):343-8. doi: 10.1210/jc.2009-1834. Epub 2009 Nov 11.

PMID:
19906783
17.

[Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome].

Knebel B, Janssen OE, Hahn S, Nitzgen U, Jacob S, Haas J, Mack S, Müller-Wieland D, Kotzka J.

Dtsch Med Wochenschr. 2009 May;134(20):1040-6. doi: 10.1055/s-0029-1222564. Epub 2009 May 6. German.

PMID:
19421925
18.

Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany.

Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M, Elsenbruch S.

Hum Reprod. 2009 Jun;24(6):1446-51. doi: 10.1093/humrep/dep031. Epub 2009 Feb 16.

PMID:
19223290
19.

Disturbed stress responses in women with polycystic ovary syndrome.

Benson S, Arck PC, Tan S, Hahn S, Mann K, Rifaie N, Janssen OE, Schedlowski M, Elsenbruch S.

Psychoneuroendocrinology. 2009 Jun;34(5):727-35. doi: 10.1016/j.psyneuen.2008.12.001. Epub 2009 Jan 15.

PMID:
19150179
20.

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society.

Fertil Steril. 2009 Feb;91(2):456-88. doi: 10.1016/j.fertnstert.2008.06.035. Epub 2008 Oct 23. Review.

PMID:
18950759

Supplemental Content

Loading ...
Support Center